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INTRODUCTION
One of the main functions of the esophagus is to
transport food bollus from the mouth to the stomach.
During this process, the esophagus is exposed to various
toxic substances, including drugs, which could damage
the esophageal squamous epithel.1
Drug-induced esophagitis or esophageal damage due
to drugs was first reported by Pemberton in the year
1970.2-4 Esophageal damage was caused by the use of
oral potassium chloride.
Drug-induced esophagitis is damage of the
esophageal mucosa due to local effects of drugs.3
There are over 70 kinds of drugs that could induce
damage of the esophagus.1,3 Several drugs related to
drug-induced esophagitis are as follows:1,3,5
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ABSTRACT
There are several factors that involve in drug induced esophagitis such as: drugs, esophagus, patients.
The drug can cause direct effect to the esophageal mucosa. The drugs that often cause esphagitis: alendronate,
tetracycline and its derivates and anti retroviral agents. Most of these drugs can cause esophageal damage
due to corrosive nature of the drug.
Esophageal factor that can cause the drug induced esophagitis: rheumatic heart disease, enlargement of
the left atrium mass and aortal aneorysma. These conditions will disturb drug passage and prolongs drug
contact with esophageal mucosa. The patients factor that influences this problem is the patients position
when taking the drug, the patients age, the amount of water taken along with the drug, the time when drug
was taken, and the amount of saliva.
Endoscopy is a good procedure to evaluate the esophageal mucosa and establishing differential
diagnosis through direct inspection, biopsy.
In the management of esophagitis, PPIs are currently the most effectiveness agents available for treating
esophagitis. Esomeprazole, an optical isomer of omeprazole is the first PPI to show greater efficacy than
other PPI is in esophagitis healing.
Key Words: Esophagitis, drug induced, proton pump inhibitor.
Table 1. Drugs That Cause Drug-Induced Esophagitis 
Antibiotics 
 Doxycycline 
 Tetracycline 
 Clyndamycin 
 Erythromycin 
 Penicillin 
Non-Steroidal Anti Inflammation 
Potassium Chloride 
Ascorbic Acid 
Sulphasferrosus 
Quinidine 
Anti-retroviral agents 
 Zalcitabine 
 Zidovudine 
Alendronate (Fosanax) 
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The extent of damage varies from mild,
asymptomatic inflammatory changes that can only be
discovered by means of endoscopy or absence of
histological changes, to severe damage accompanied by
ulcer and stricture. Damage is often acute, and self heals
without any sequel. Symptoms subside 10 days
following termination of treatment.4
Collin et al reported 41 cases of drug-induced
esophagitis caused by eight different kinds of drugs, nine
of which resulted in death.4 Setijoso et al reported four
cases out of 12 patients with non-cardiac acute chest
pain undergoing endoscopy.7
Luigi Bonavina, in a retrospective study of patients
with esophageal stricture, found 20% out of 55 to be
drug-induced.8
Drug-induced esophagitis is often found in old age
and women.3,4
This paper discusses the pathogenesis, diagnosis,
treatment, and several drugs that cause drug-induced
esophagitis.
PHYSIOLOGY OF ESOPHAGEAL MUCOSAL INTEGRITY
The physiology of esophageal integrity is determined
by 2 factors as follows:
• mucosal offensive factors
• mucosal defense factors
Offensive mucosal factors are those that destroy the
mucosa. They include gastric secretion, pylloric
competence, drugs and acidic or alkaline substances.
Defense mucosal factors comprise of anti-reflux
barrier, lumen clearance, and tissue resistance.8,9
ANTI-REFLUX BARRIER
Anti-reflux barrier is an esophageal defense factor
in maintaining the mucosa. The anti-reflux barrier limits
the frequency and volume of the reflux from the gaster
to the esophagus. The anti-reflux barrier comprises of
the lower esophageal sphincter, the intra-abdominal
esophageal segment and the diagphramatic crura.
ESOPHAGEAL LUMEN CLEARANCE
The esophageal lumen clearance includes gravity,
peristalsis, and acid clearance, particularly with
bicarbonate secretion from the saliva and esophageal
glands. Gravity increases bolus clearance from the
esophagus to the gaster when standing. During sleep,
peristalsis and bicarbonate secretion play a more
important role in the esophageal lumen clearance
process.
TISSUE RESISTANCE
Tissue resistance is not a single factor, but a unity of
the intrinsic structure of the mucosa and esophageal
function that interacts dynamically to minimize mucosal
damage during contact with hazardous substances.
Tissue resistance consists of pre-epithelial, epithelial, and
post-epithelial defense mechanisms.8,9
PRE-EPITHELIAL DEFENSE MECHANISM
The most important pre-epithelial defense mechanism
is the mucous layer, the unstirred water layer, and the
bicarbonate complex. The mucous layer resembles a gel
that prohibits bacterial adherence to the epithel, and
epithelial exposure to hazardous substances.
Bicarbonate secretion by the cell surface into the unstirred
layer protects cell damage due to lumen acidity by
creating an alkaline condition from H+ ion re-diffusion.8,9
EPITHELIAL DEFENSE MECHANISM
Epithelial defense mechanism comprise of structural
and functional cell components. Structural cell
components consists of the cell membrane and
intercellular junctional complex that protect damage from
acids by inhibiting H+ ion re-diffusion into the cell and
intercellular spaces between the epithel.8,9
POST-EPITHELIAL DEFENSE MECHANISMS
Post-epithelial defense mechanism is regulated by
blood flow. Blood flow transports oxygen, nutrients, and
bicarbonate, as well as releases H+ ions and CO2.8,9
PATHOGENESIS
Drug-induced esophagitis involve several factors, as
follows:4
• drugs
• esophagus
• patient
DRUG FACTORS
Esophageal damage occurs due to direct effect of
the drug to the esophageal mucosa and caustic effect as
well as the pH of the drug, which will change the barrier
of the esophageal mucosa, thus prolonging drug contact
with the esophageal mucosa and will damage the
esophageal wall, causing esophagitis.4,7,8,11
The effect of the damage that occurs varies, since it
is influenced by various factors such as the chemical
nature, the concentration of chemical substances, drug
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formulation, such as tablet, capsule, liquid, as well as
combination with other substances.4
A near acidic pH of the drug, such as iron sulphate,
doxy and tetracycline, and vitamin C will create severe
damage of the esophagus.4
An in vitro study on drug pH changes prior and
following dilution with 10 ml of saliva demonstrate near
acid pH changes for tetracycline, salicil acid, and
vitamin C,4,7 while the potassium chloride and quinidine
do not cause pH changes. Thus, it is suspected that the
level of local drug is the factor causing damage of the
esophageal mucosa.7
and distal esophagus delays drug passage. In normal
subjects, the aortal arc is the most common location of
esophageal damage.
PATIENT FACTORS
The patient factor that influences drug-induced
esophagitis is the patient’s position when taking the drug,
the patient’s age, the amount of water taken along with
the drug, the time when the drug was taken, and the
amount of saliva.4 In several studies, drug-induced
esophagitis was often found in patients taking drugs in a
sleeping position. Elderly patients have a reduced
production of saliva, and reduced esophageal motility,
thus facilitating drug-induced esophagitis.
ESTABLISHING DRUG-INDUCED ESOPHAGITIS
The diagnosis of drug-induced esophagitis is
established based on history, esophagography evaluation,
and endoscopy.
HISTORY
Retrosternal pain is the most frequent complaint (61-
72%) occurring after drug intake.1,4,5,10,11 Odinophagy,
or pain when ingesting, is found in 20-40% of patients. It
is caused by stimulation of pain receptors on the
esophageal mucosa. Odinophagy is often caused by
antibiotics, non-steroidal inflammatory agents, and
alendronate. Administration of antibiotics such as
doxycycline, after dilution with saliva, there is a change
of pH towards acid. Such pH changes would stimulate
chemical receptors on the esophageal mucosa, thus
inducing pain.1,4,5,10,12 Disphagia found in 20-40% of
patients due to esophageal stricture or stenosis is often
found in patients receiving potassium chloride, quinidine,
and alendronate.1,4,5,7
Quinidine can cause severe esophageal damage with
stricture without causing any pain.4
ESOPHAGOGRAPHY
Most patients with drug-induced esophagitis without
complications undergo esophagogram examination
using normal contrast.4 In the year 1983, Kikendal, et al,
found 8 cases out of 143 with discrete ulcer during
esophagogram. While Sakai et al found ulcer in 4 out of
6 cases using the double contrast technique.
Esophagography with contrast also assists the
evaluation of external esophageal pressure, which plays
a role in the pathogenesis of drug-induced esophagitis.4
Table 2. pH Changes Prior to Drug pH Diluted with 10 ml Saliva 
Drug Saliva pH Time for dilution pH following dilution 
KCl (slow release) 6.3 >72 degrees Celsius 6.5 
KCl elixir 6.4   
Doxycycline 6.1 37 3.2 
Aspirin 6.3 5 3.4 
Ascorbic acid 6.2 58 2.8 
Tetracycline 6.2 42 1.6 
Sodium phenitoine 6.2 15 10.4 
Gluconic quinidine 6.4 >72 degrees Celsius 6.9 
 
Large tablets such as gluconic quinidine with a 12
cm diameter of ½ from the normal esophageal lumen
causes esophageal damage.4
Gelatin capsules will become sticky during the
dilution process if not taken with adequate amounts of
water or going through a long transit time.4 The capsule
will get stuck in the esophagus and cause esophageal
damage.4 A study on esophageal transit on 18
volunteers with a gelatin capsule taken with 15 ml of
water demonstrated that in 11 out of 18 volunteers, the
capsule would get stuck in the esophagus, while the
gelatin capsule only got stuck in 3 out of 18 volunteers
when taken with 120 ml of water.7
Aspirin and other non-steroidal anti-inflammatory
agents cause direct caustic effect and a pH that changes
the esophageal mucosal barrier in the process of
cyto-protection.
ESOPHAGEAL FACTOR
In a great number of patients with drug-induced
esophagitis, no esophageal disorder, neuro-motor
abnormality, or obstruction is found. Thus, the main cause
of esophageal damage is the chemical nature of the drug,
drug formulation, and the patient’s position when
ingesting the drug.4
Rheumatic heart disease, enlargement of the left
atrium, following surgery for mediastinal abnormality,
mass, and aortal aneurysm, disturb drug passage and
prolongs contact with the esophageal mucosa.4
Narrowing of the esophageal lumen of the aortal arc
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ENDOSCOPY
Endoscopy is a good technique for determining
damage of the esophageal mucosa and establishing
differential diagnosis through direct inspection, biopsy,
and cytological examination, as well as microbiological,
when indicated. Abnormal endoscopy is found in 99%
of all patients with drug-induced esophagitis. When
indicated, examination is performed immediately after
the onset of complaints.
During endoscopic examination, discrete erosions or
ulcerations are found from pin-point to circumferential
sizes over 6 cm in diameter. Focal ulceration or erosion
with the absence of stenosis is found after
administration of antibiotics, non-steroidal anti-
inflammatory agents, and emepromium bromide.16
Drug-induced esophagitis due to quinidine, potassium
chloride, and alendronate demonstrated mucosal erosion
or ulceration and bleeding during endoscopic evaluation.4-
6
 Endoscopic evaluation is not an indication for patients
with a history and chronology of acute retrosternal pain
and drug-associated odinophagy.
VARIOUS DRUGS THAT OFTEN CAUSE ESOPHAGITIS
1. Alendronate
Sodium alendronate is an osteoclast-selective
inhibitor that prevents bone resorption. Alendronate is
used for treatment of post-menopause osteoporosis. The
drug increases bone mass, reduces the incidence of
vertebral fracture, and deformity.
The use of 40 mg of alendronate daily increases the
incidence of upper gastrointestinal tract disturbance,
including esophagitis and gastritis.
The pathophysiology of esophageal damage due to
alendronate is caused by direct irritation of the
esophageal mucosa and gastric acid reflux containing
drug substances. Disturbed passage of alendronate  tablet
prolongs the contact between the drug and the
esophageal mucosa.
After-sales studies on esophageal damage due to use
of alendronate demonstrate 199 out of 1213 patients with
damage of the esophageal mucosa.14,15 Damage of the
esophageal mucosa varies, as can be found in the
following table.
According to endoscopic diagnosis, damage due to
alendronate may inflict all of the middle and distal
esophagus.
The onset of the incidence of symptoms in this study
is one week, one month, and two months after
administration of alendronate. Several factors that
influence esophageal damage in this study are as
follows: the amount of water taken during drug
ingestion, body position, and the time of drug intake.14,15
Esophageal damage is found in patients taking less than
180 ml of water. Patients taking the drug while not
standing for approximately 30 minutes had a higher
chance of esophageal damage. The same was true for
those taking the drug before bed. These factors prolong
contact/irritation of the esophageal mucosa by the drug,
thus causing esophageal damage.
2. Tetracycline and its derivatives
Tetracycline and its derivatives are drugs that
commonly cause esophagitis. Esophageal damage is
caused by the corrosive nature of the drug. The pH of
the drug changes to acidic after dissolving in saliva.4,7,16
There are several reports of tetracycline-related
esophagitis, where severe esophagitis occuring after
ingestion of tetracycline with inadequate intake of water
right before bed.16
Esophagitis has been reported in malaria patients
treated with quinine and doxycycline. Patients
complained of hiccups, and endoscopic evaluation found
erosion and esophageal ulcer.17,18
3. Anti-retroviral agents
Zidovudine is an anti-retroviral agent that inhibits in
vitro replication of the HIV. Zidovudine is used for the
treatment of AIDS and AIDS-related complex.
In drug-induced esophagitis due to zidovudine,
abnormality in the form of ulcer is found in the esopha-
gus, particularly multi-circumferential ulcer and large,
single ulcers. In the patient, there was history of drug
intake without water, in a sleeping position.19
TREATMENT
Drug-induced esophagitis caused by various drugs,
all causing focal esophagitis, rarely with complications.
The best treatment is termination of the drug in addition
to supportive treatment.1
Table 3. Esophageal Damage in Patients Receiving 
Alendronate Treatment 
Esophageal damage Number of patients 
Serious or severe 51 
Esophageal ulcer 22 
Esophagitis 21 
Odinophagia 12 
Dysphagia 11 
Regurgitation or dyspepsia 5 
Reflux esophagitis 4 
Hematemesis or bleeding 2 
Stricture 2 
Quoted from 14,15 
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Termination of the drug alleviates complaints and causes
spontaneous healing. Analgetics are administered to
eliminate the pain. H2 receptor antagonists are
administered to reduce esophageal damage due to acid.
PPI such as omeprazole, rabeprazole, and lanzoprazole
can be used to reduce pH of gastric juice. In a majority of
patients, once daily PPI therapy in the morning gives
prompt relief of heartburn and heals esophagitis, within
eight weeks. PPI should be given twice daily to patients
who have   responded poorly to a standard once daily
dose.20 Esomeprazole, an optical isomer of omeprazole is
the first PPI to show greater efficacy that omeprazole in
esophagitis erosive healing. The study from Castell et al.,
showed Esomeprazole (40 mg) demonstrated significantly
higher healing rats than lansoprazole at week 8.21
Patients with odynophagia with lack of oral intake
may be given intravenous fluids.1,4,6
If esophageal stricture develops due to quinidine,
potassium chloride and alendronate, perform dilatation
and gauging.
CONCLUSION
1. Drug-induced esophagitis refers to damage of the
esophageal mucosa due to local drug effects.
2. The pathogenesis of drug-induced esophagitis is by
direct effect of the drug on the esophageal mucosa
and caustic effect as well as drug pH, causing
changes of the esophageal mucosal barrier.
3. Risk factors for drug-induced esophagitis are as
follows:
• Drug formulation, tablet size
• Patient’s age
• History of chest surgery
• Enlarged left atrium
• The time, position, and amount of fluid intake
during drug ingestion
SUGGESTION
Patients with high risk, particularly those receiving
drugs that can potentially cause drug-induced
esophagitis, should receive adequate education.
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